Charles River Laboratories International, Inc.Share Price
|
|
Share Price & Volume
| Previous Close | $167.37 | |
| Open | -0.38% | $166.73 |
| Day Low | -0.54% | $166.47 |
| Day High | +1.67% | $170.16 |
| 52-Week Low | -45.12% | $91.86 |
| 52-Week High | +36.75% | $228.88 |
| Day Volume | 357,031 | |
| Average Volume | 914,137 | |
| EPS (TTM) | -$2.91 | |
| P/E (TTM) | -58.04x | |
| FWD P/E (NTM) | 16.29x | |
| Next Earnings Date | May 6, 2026 |
| Market Cap | 8,315,067,698 | |
| Shares Outstanding (Millions) | 49,227,800 | |
| Dividend | - | |
| Beta | 1.65 | |
| ROE | -0.04% | |
| ROA | 0.04% |
Analyst Ratings and Price Targets
Current:
$168.91
Average:
$211.50
(+25.21%)
Low:
$175.00
(+3.61%)
High:
$265.00
(+56.89%)
| UBS | Maintains | Neutral | $175.00 | +3.61% | Feb 25, 2026 |
| TD Cowen | Maintains | Buy | $235.00 | +39.13% | Feb 20, 2026 |
| Mizuho | Maintains | Neutral | $175.00 | +3.61% | Feb 20, 2026 |
| Barclays | Maintains | Overweight | $200.00 | +18.41% | Feb 19, 2026 |
| Evercore ISI Group | Maintains | Outperform | $200.00 | +18.41% | Feb 19, 2026 |
| Citigroup | Maintains | Buy | $265.00 | +56.89% | Jan 16, 2026 |
| Evercore ISI Group | Maintains | Outperform | $260.00 | +53.93% | Jan 13, 2026 |
| Mizuho | Maintains | Neutral | $200.00 | +18.41% | Dec 18, 2025 |
| Barclays | Maintains | Overweight | $215.00 | +27.29% | Dec 15, 2025 |
| JP Morgan | Maintains | Neutral | $190.00 | +12.49% | Dec 15, 2025 |
Headquarters
Wilmington, MA, USA
Industry
# of Employees
18,700